Join the club for FREE to access the whole archive and other member benefits.

Shai Efrati

Shai Efrati is an Israeli physician, an associate professor at the Sackler Faculty of Medicine and the Sagol School of Neuroscience

In 2008, Efrati founded and now directs the Sagol Center for Hyperbaric Medicine and Research at Tel Aviv University and Yitzhak Shamir Medical Center, where he oversees and collaborates with other scientists and manages a large hyperbaric medicine and research facility. The center currently treats up to 200 patients per day.

Efrati has initiated a research program focusing on neuroplasticity and  cognitive rehabilitation by the use of Hyperbaric Oxygen Therapy (HBOT). The clinical results gained from the research program have led to ongoing cooperation between a multidisciplinary team focused on the regenerative effects of hyperbaric oxygen in various brain injuries.


Visit website: https://en.wikipedia.org/wiki/Shai_Efrati

 ?originalSubdomain=il

See also: Health Organisation The Sagol Center for Hyperbaric Medicine - One of the largest Hyperbaric centers worldwide

Details last updated 05-Feb-2020

Shai Efrati is also referenced in the following:

Longevity Med Summit

04-May-2023 to 05-May-2023

Annual gathering of the entire longevity ecosystem to tackle the aging problem

Longevity Nation 2024

28-Oct-2024

Conference Enhancing Research, Development and Education for Healthy Longevity organized by Vetek Association (Tel Aviv, Israel)

Shai Efrati News

Oxygen therapy reversed the human age biologically

Oxygen therapy reversed the human age biologically

YAHOO! - 18-Nov-2020

Not as easy as taking a pill, but a stunning result on both telomeres and senescent cells

Brain ageing reversed by Israeli doctor through an oxygen chamber

Brain ageing reversed by Israeli doctor through an oxygen chamber

The times of Israel - 15-Jul-2020

Don't try this at home! Too much oxygen (hyperoxia) is definitely bad for you

Hyperbaric oxygen therapy's impact on cardiac function

Hyperbaric oxygen therapy's impact on cardiac function

Jerusalem Post - 04-Feb-2020

Protocols were evaluated on the patients with “normal” aging heart